Update shared on16 Sep 2025
Fair value Increased 2.20%Swiss Life Holding's consensus price target was modestly raised to CHF801.73, driven by improving earnings growth expectations, resilient fee and risk income, and strong cost discipline, despite some caution over macroeconomic headwinds following recent share price gains.
Analyst Commentary
- Expectations of improved earnings growth supported modest price target increases.
- Bullish analysts cite resilient fee and risk income trends as key drivers.
- Positive outlook on cost discipline and capital generation underpins upward adjustments.
- Bearish analysts highlight limited upside following recent share price outperformance.
- Some caution around macroeconomic uncertainty impacting new business flows.
Valuation Changes
Summary of Valuation Changes for Swiss Life Holding
- The Consensus Analyst Price Target has risen slightly from CHF784.45 to CHF801.73.
- The Discount Rate for Swiss Life Holding remained effectively unchanged, moving only marginally from 4.40% to 4.46%.
- The Net Profit Margin for Swiss Life Holding remained effectively unchanged, moving only marginally from 16.09% to 16.30%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.